Galapagos NV
GLPG
#4565
Rank
HK$17.00 B
Marketcap
HK$257.99
Share price
0.36%
Change (1 day)
29.18%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -HK$2.52

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -HK$2.64. In 2024 the company made an earnings per share (EPS) of HK$9.08 a decrease over its 2023 EPS that were of HK$27.65.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.52-127.76%
2024HK$9.08-67.16%
2023HK$27.65-199.64%
2022-HK$27.7599.03%
2021-HK$13.94-68.98%
2020-HK$44.95-298.06%
2019HK$22.69-554.64%
2018-HK$4.99-77.18%
2017-HK$21.88-326.21%
2016HK$9.67-134.19%
2015-HK$28.29-371.34%
2014HK$10.42-445.98%
2013-HK$3.0132.88%
2012-HK$2.27-82.07%
2011-HK$12.65-817.9%
2010HK$1.7612.73%
2009HK$1.56-120.79%
2008-HK$7.52-37.67%
2007-HK$12.0639.64%
2006-HK$8.6428.17%
2005-HK$6.746.25%
2004-HK$6.34

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
AstraZeneca
AZN
HK$23.65-994.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
HK$81.34-3,178.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.87-1,192.75%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
HK$10.53-498.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
-HK$4.75 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.78-2,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.91-285.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
HK$28.02-1,160.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
HK$59.17-2,339.29%๐Ÿ‡บ๐Ÿ‡ธ USA